FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2803828411> ?p ?o ?g. }

• W2803828411 endingPage "2912" @default.
• W2803828411 startingPage "2903" @default.
• W2803828411 abstract "Standard of care for patients with symptomatic, advanced-stage follicular lymphoma (FL) is rituximab-containing chemoimmunotherapy followed by rituximab maintenance. This prospective, multicenter, noninterventional study analyzed how efficacy and safety data from randomized controlled trials translate into clinical practice in Germany. Both treatment-naïve and relapsed/refractory patients with FL, who responded to rituximab-containing induction and were scheduled for rituximab maintenance, were observed for 24 months. Effectiveness was measured by response and Kaplan-Meier survival analysis. In addition, treatment patterns of induction and maintenance, as well as adverse events, were documented. The evaluable study population consisted of 310 first-line patients and 173 relapsed/refractory patients, including 116 patients with initial Ann-Arbor stage I/II and 20 patients with FL grade 3B. Regarding first-line induction, a shift from R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) to R-bendamustine was observed over time, as well as a decline in radiotherapy. 2-year progression-free survival rates were 88.3% (95% confidence interval [CI] 84.0-92.6) for first-line patients and 76.0% (95% CI: 68.8-83.3) for relapsed/refractory patients. Conversion from partial to complete remission (PR, CR) occurred in 53.4% of analyzed first-line patients with PR, resulting in 69.4% CRs at study end (relapsed/refractory: conversion in 42.9%, final CRs 57.9%). Safety results were consistent with the known safety profile of rituximab in this setting. Both treatment-naïve and relapsed/refractory patients with FL show favorable 2-year PFS rates and improvements in the remission status with postinduction rituximab monotherapy as maintenance and consolidation therapy." @default.
• W2803828411 created "2018-06-01" @default.
• W2803828411 creator A5023251571 @default.
• W2803828411 creator A5030372221 @default.
• W2803828411 creator A5037133409 @default.
• W2803828411 creator A5048726579 @default.
• W2803828411 creator A5055375714 @default.
• W2803828411 creator A5067362315 @default.
• W2803828411 creator A5067656237 @default.
• W2803828411 creator A5084125338 @default.
• W2803828411 creator A5085255418 @default.
• W2803828411 creator A5090086499 @default.
• W2803828411 date "2018-05-15" @default.
• W2803828411 modified "2023-10-15" @default.
• W2803828411 title "Rituximab maintenance therapy of follicular lymphoma in clinical practice" @default.
• W2803828411 cites W1555251655 @default.
• W2803828411 cites W1576880656 @default.
• W2803828411 cites W1587432558 @default.
• W2803828411 cites W1845110614 @default.
• W2803828411 cites W1969582706 @default.
• W2803828411 cites W2061272096 @default.
• W2803828411 cites W2075141373 @default.
• W2803828411 cites W2101648653 @default.
• W2803828411 cites W2114233385 @default.
• W2803828411 cites W2118600784 @default.
• W2803828411 cites W2127749132 @default.
• W2803828411 cites W2139942643 @default.
• W2803828411 cites W2147757009 @default.
• W2803828411 cites W2154643481 @default.
• W2803828411 cites W2155724413 @default.
• W2803828411 cites W2156522119 @default.
• W2803828411 cites W2169209759 @default.
• W2803828411 cites W2169578616 @default.
• W2803828411 cites W2304617849 @default.
• W2803828411 cites W2310716991 @default.
• W2803828411 cites W2344768254 @default.
• W2803828411 cites W2602518840 @default.
• W2803828411 cites W2624203656 @default.
• W2803828411 cites W4249178543 @default.
• W2803828411 doi "https://doi.org/10.1002/cam4.1549" @default.
• W2803828411 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6051161" @default.
• W2803828411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29761908" @default.
• W2803828411 hasPublicationYear "2018" @default.
• W2803828411 type Work @default.
• W2803828411 sameAs 2803828411 @default.
• W2803828411 citedByCount "5" @default.
• W2803828411 countsByYear W28038284112019 @default.
• W2803828411 countsByYear W28038284112020 @default.
• W2803828411 countsByYear W28038284112022 @default.
• W2803828411 crossrefType "journal-article" @default.
• W2803828411 hasAuthorship W2803828411A5023251571 @default.
• W2803828411 hasAuthorship W2803828411A5030372221 @default.
• W2803828411 hasAuthorship W2803828411A5037133409 @default.
• W2803828411 hasAuthorship W2803828411A5048726579 @default.
• W2803828411 hasAuthorship W2803828411A5055375714 @default.
• W2803828411 hasAuthorship W2803828411A5067362315 @default.
• W2803828411 hasAuthorship W2803828411A5067656237 @default.
• W2803828411 hasAuthorship W2803828411A5084125338 @default.
• W2803828411 hasAuthorship W2803828411A5085255418 @default.
• W2803828411 hasAuthorship W2803828411A5090086499 @default.
• W2803828411 hasBestOaLocation W28038284111 @default.
• W2803828411 hasConcept C121332964 @default.
• W2803828411 hasConcept C126322002 @default.
• W2803828411 hasConcept C141071460 @default.
• W2803828411 hasConcept C142424586 @default.
• W2803828411 hasConcept C143998085 @default.
• W2803828411 hasConcept C197934379 @default.
• W2803828411 hasConcept C2776694085 @default.
• W2803828411 hasConcept C2776755627 @default.
• W2803828411 hasConcept C2777058707 @default.
• W2803828411 hasConcept C2778283404 @default.
• W2803828411 hasConcept C2778720950 @default.
• W2803828411 hasConcept C2779338263 @default.
• W2803828411 hasConcept C2779429289 @default.
• W2803828411 hasConcept C2780653079 @default.
• W2803828411 hasConcept C2780790343 @default.
• W2803828411 hasConcept C2781442060 @default.
• W2803828411 hasConcept C2908647359 @default.
• W2803828411 hasConcept C71924100 @default.
• W2803828411 hasConcept C87355193 @default.
• W2803828411 hasConcept C90924648 @default.
• W2803828411 hasConcept C99454951 @default.
• W2803828411 hasConceptScore W2803828411C121332964 @default.
• W2803828411 hasConceptScore W2803828411C126322002 @default.
• W2803828411 hasConceptScore W2803828411C141071460 @default.
• W2803828411 hasConceptScore W2803828411C142424586 @default.
• W2803828411 hasConceptScore W2803828411C143998085 @default.
• W2803828411 hasConceptScore W2803828411C197934379 @default.
• W2803828411 hasConceptScore W2803828411C2776694085 @default.
• W2803828411 hasConceptScore W2803828411C2776755627 @default.
• W2803828411 hasConceptScore W2803828411C2777058707 @default.
• W2803828411 hasConceptScore W2803828411C2778283404 @default.
• W2803828411 hasConceptScore W2803828411C2778720950 @default.
• W2803828411 hasConceptScore W2803828411C2779338263 @default.
• W2803828411 hasConceptScore W2803828411C2779429289 @default.
• W2803828411 hasConceptScore W2803828411C2780653079 @default.
• W2803828411 hasConceptScore W2803828411C2780790343 @default.
• W2803828411 hasConceptScore W2803828411C2781442060 @default.

• next